OurPet's Reaches Settlement With Another Competitor Over OurPet's Play 'N Squeak Patent


FAIRPORT HARBOR, OH--(Marketwire - November 4, 2009) - OurPet's Company (OTCBB: OPCO) (www.ourpets.com), a leading proprietary pet supply company, today announced a patent infringement settlement.

In June 2009, OurPet's filed a patent infringement lawsuit in the United States District Court for the Northern District of Ohio against Multipet International, Inc., a pet supply company located in Moonachie, New Jersey (Case No. 1:09-cv-1458). In the lawsuit, OurPet's alleged that Multipet engaged in conduct that infringed upon OurPet's 6,371,053 ('053) patent, which is for a simulated mouse toy having a prerecorded sound chip and sold by OurPet's under the Play-N-Squeak® label. The parties recently reached an amicable resolution in which there were no findings or admissions for or against any party. As part of that resolution, OurPet's was financially compensated and Multipet agreed to terminate sales of its Look Who's Talking™ for cat pet mouse toy after an agreed wind-down period. Multipet further admitted to the validity of the OurPet's patent in suit. OurPet's was represented by lead counsel David A. Welling of Choken & Welling, LLP, Akron, Ohio, and Multipet was represented by lead counsel Randy Friedberg, White and Williams LLP, New York, NY.

About OurPet's Company

OurPet's designs, produces and markets a broad line of innovative, high-quality accessory and consumable pet products in the U.S. and overseas. Investors and customers may visit www.ourpets.com more information about the Company and its products. The Company's websites include: www.smartscoop.com, www.ecopurenaturals.com, www.playnsqueak.com, and www.flappydogtoys.com.

Certain of the matters set forth in this press release are forward-looking and involve a number of risks and uncertainties. Among the factors that could cause actual results to differ materially are the following: business conditions and growth in the industry; general economic conditions; addition or loss of significant customers; the loss of key personnel; product development; competition; risks of doing business abroad; foreign government regulations; fluctuations in foreign rates; rising costs for raw materials and the unavailability of sources of supply; the timing of orders booked; and the other risks that are described from time to time in OurPet's SEC reports.

Contact Information: CONTACT: OurPet's Company Dr. Steven Tsengas (440) 354-6500 (Ext. 111) INVESTOR RELATIONS: Robert A. Lentz and Associates, Inc. Robert Lentz (614) 876-2000